CA2414352A1 - Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies - Google Patents

Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies Download PDF

Info

Publication number
CA2414352A1
CA2414352A1 CA002414352A CA2414352A CA2414352A1 CA 2414352 A1 CA2414352 A1 CA 2414352A1 CA 002414352 A CA002414352 A CA 002414352A CA 2414352 A CA2414352 A CA 2414352A CA 2414352 A1 CA2414352 A1 CA 2414352A1
Authority
CA
Canada
Prior art keywords
treating
neuropathies
peripheral
derivative
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002414352A
Other languages
English (en)
French (fr)
Inventor
Ralph E. Wood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2414352A1 publication Critical patent/CA2414352A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA002414352A 2000-06-30 2001-06-29 Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies Abandoned CA2414352A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US21506500P 2000-06-30 2000-06-30
US60/215,065 2000-06-30
US21902900P 2000-07-18 2000-07-18
US60/219,029 2000-07-18
PCT/US2001/041202 WO2002002118A1 (en) 2000-06-30 2001-06-29 Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies

Publications (1)

Publication Number Publication Date
CA2414352A1 true CA2414352A1 (en) 2002-01-10

Family

ID=26909649

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002414352A Abandoned CA2414352A1 (en) 2000-06-30 2001-06-29 Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies

Country Status (13)

Country Link
EP (1) EP1303279A1 (ja)
JP (1) JP2004511433A (ja)
KR (1) KR20030047907A (ja)
CN (1) CN1440287A (ja)
AU (1) AU2001279275A1 (ja)
BR (1) BR0112100A (ja)
CA (1) CA2414352A1 (ja)
HU (1) HUP0301451A3 (ja)
IL (1) IL153426A0 (ja)
MX (1) MXPA03000033A (ja)
NZ (1) NZ523108A (ja)
PL (1) PL365565A1 (ja)
WO (1) WO2002002118A1 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0020588D0 (en) * 2000-08-21 2000-10-11 Pfizer Ltd Treatment of wounds
US8133903B2 (en) 2003-10-21 2012-03-13 Los Angeles Biomedical Research Institute at Harbor—UCLA Medical Center Methods of use of inhibitors of phosphodiesterases and modulators of nitric oxide, reactive oxygen species, and metalloproteinases in the treatment of peyronie's disease, arteriosclerosis and other fibrotic diseases
EP1605925A1 (en) * 2003-03-17 2005-12-21 Pfizer Products Inc. Treatment of type 1 diabetes with pde5 inhibitors
FR2877013A1 (fr) * 2004-10-27 2006-04-28 Assist Publ Hopitaux De Paris Indentification d'une mutation de jak2 impliquee dans la polyglobulie de vaquez
WO2006074443A2 (en) * 2005-01-07 2006-07-13 The Johns Hopkins University Pde5 inhibitor compositions and methods for immunotherapy
MX2017016930A (es) * 2017-12-19 2019-06-20 Malesil Research & Tech Llc Uso del maleato de sildenafil en el tratamiento de ulceras de pie diabetico.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6043252A (en) * 1997-05-05 2000-03-28 Icos Corporation Carboline derivatives
US6075028A (en) * 1999-09-23 2000-06-13 Graham; Richard Method of treating Tourette's syndrome and related CNS disorders

Also Published As

Publication number Publication date
WO2002002118A1 (en) 2002-01-10
AU2001279275A1 (en) 2002-01-14
EP1303279A1 (en) 2003-04-23
HUP0301451A2 (hu) 2003-09-29
KR20030047907A (ko) 2003-06-18
NZ523108A (en) 2005-04-29
JP2004511433A (ja) 2004-04-15
HUP0301451A3 (en) 2004-10-28
IL153426A0 (en) 2003-07-06
MXPA03000033A (es) 2003-09-25
PL365565A1 (en) 2005-01-10
BR0112100A (pt) 2003-05-20
CN1440287A (zh) 2003-09-03

Similar Documents

Publication Publication Date Title
CN101287457B (zh) Treprostinil用于治疗神经性糖尿病的足部溃疡的用途
JP2002506023A (ja) 粘膜炎の処置および予防のための方法および組成物
KR20070032619A (ko) 폐동맥 고혈압의 치료를 위한 일로프로스트의 복합 치료제
JP2002523370A5 (ja)
JP2002528502A5 (ja)
CA2559239A1 (en) Use of simethicone and sodium picosulphate in constipated patients suffering from bloated feeling and gas discomfort during the night
CA2433833A1 (en) Use of flumazenil in developing a drug for the treatment of alcohol dependence
CA2414352A1 (en) Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies
JP2005525329A5 (ja)
RU2543635C2 (ru) Способ и фармацевтические композиции для лечения постпрандиальной гипергликемии диабета ii типа введением через слизистую ротовой полости
JP2002534477A (ja) メラガトランの新規使用
JP2005501068A (ja) 特に眼科分野における適用のための外傷および損傷の治癒および／または修復のための治療に適したアミノ酸組成物
JPH01261334A (ja) アンギオテンシン転換酵素阻害剤を有効成分とした医療用調剤及びその製造方法
AU2002220960B2 (en) Regeneration of blood vessels
CA2493208A1 (en) Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
CA2474430A1 (en) A combination of a thrombolytic agent and levosimendan for the treatment of acute myocardial infarction
WO2004028457A3 (en) PHARMACEUTICAL COMPOSITION FOR IMPROVED ADMINISTRATION OF HIV gp41-DERIVED PEPTIDES, AND ITS USE IN THERAPY
CA2590224A1 (en) Method for reduction, stabilization and prevention of rupture of lipid rich plaque
CA2474703A1 (en) Therapeutic agent of glaucoma comprising bunazosin and prostaglandins
AU2002220960A1 (en) Regeneration of blood vessels
MD1568G2 (ro) Metodă de tratament al bolii arşilor în perioada şocului combustional
RU2003106417A (ru) Применение комбинации витаминов для лечения первичных головных болей
JPH0959149A (ja) 消炎鎮痛組成物
CN117243947A (zh) 瑞香素及包含其的组合在制备糖尿病并发症药物中的应用
ATE284696T1 (de) Pharmazeutische zusammensetzung enthaltend salmeterol und budesonid zur behandlung von atemkrankheiten

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued